First trimester down's syndrome screening shows high detection rate for trisomy 21, but poor performance in structural abnormalities - Regional outcome Results

Fetal Diagnosis and Therapy

Volumn 22, Issue 1, 2006, Pages 45-50

  Rissanen, Anne ^a   Niemimaa, Marko ^b   Suonpää, Mikko ^c   Ryynänen, Markku ^b   Heinonen, Seppo ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

^c Wallac Oy   (Finland)

Author keywords

First trimester; Screening

Indexed keywords

CHORIONIC GONADOTROPIN; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; ARTICLE; CHROMOSOME STRUCTURE; CLINICAL PRACTICE; CONGENITAL HEART MALFORMATION; DOWN SYNDROME; FEMALE; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; GENETIC SCREENING; GESTATIONAL AGE; HUMAN; NUCHAL TRANSLUCENCY MEASUREMENT; PRIORITY JOURNAL; PROTEIN DETERMINATION; SAMPLE SIZE; SCREENING TEST; SECOND TRIMESTER PREGNANCY; STRUCTURE ANALYSIS; TRISOMY 13; TRISOMY 18; TRISOMY 21;

ABNORMALITIES; ADULT; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CHROMOSOME DISORDERS; FEMALE; HUMANS; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS; TRISOMY; TURNER SYNDROME;

EID: 33845734590     PISSN: 10153837     EISSN: None     Source Type: Journal    
DOI: 10.1159/000095843     Document Type: Article

References (17)

1. Niemimaa M, Suonpaa M, Perheentupa A, Seppala M, Heinonen S, Laitinen P, Ruokonen A, Ryynanen M: Evaluation of first trimester maternal serum and ultrasound screening for Down's syndrome in Eastern and Northern Finland. Eur J Hum Genet 2001;9:404-408.
2. Wapner R, Thom E, Simpson JL, Pergament E, Silver R, Filkins K, Platt L, Mahoney M, Johnson A, Hogge WA, Wilson RD, Mohide P, Hershey D, Krantz D, Zachary J, Snijders R, Greene N, Sabbagha R, MacGregor S, Hill L, Gagnon A, Hallahan T, Jackson L: First-trimester screening for trisomies 21 and 18. N Engl J Med 2003;349:1405-1413.
3. Spencer K, Spencer CE, Power M, Dawson C, Nicolaides KH: Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years prospective experience. BJOG 2003;110:281-286.
4. Hyett J, Perdu M, Sharland G, Snijders R, Nicolaides KH: Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study. BMJ 9-1-1999;318:81-85.
5. Crossley JA, Aitken DA, Cameron AD, McBride E, Connor JM: Combined ultrasound and biochemical screening for Down's syndrome in the first trimester: a Scottish multicentre study. BJOG 2002;109:667-676.
6. Schuchter K, Hafner E, Stangl G, Metzenbauer M, Hofinger D, Philipp K: The first trimester 'combined test' for the detection of Down syndrome pregnancies in 4,939 unselected pregnancies. Prenat Diagn 2002;22:211-215.
7. Spencer K, Nicolaides KH: A first trimester trisomy 13/trisomy 18 risk algorithm combining fetal nuchal translucency thickness, maternal serum free beta-hCG and PAPP-A. Prenat Diagn 2002;22:877-879.
8. Krantz DA, Hallahan TW, Orlandi F, Buchanan P, Larsen JWJ, Macri JN: First-trimester Down syndrome screening using dried blood biochemistry and nuchal translucency. Obstet Gynecol 2000;96:207-213.
9. Snijders RJ, Sebire NJ, Nicolaides KH: Maternal age and gestational age-specific risk for chromosomal defects. Fetal Diagn Ther 1995;10:356-367.
10. Ghi T, Huggon IC, Zosmer N, Nicolaides KH: Incidence of major structural cardiac defects associated with increased nuchal translucency but normal karyotype. Ultrasound Obstet Gynecol 2001;18:610-614.
11. Hafner E, Schuller T, Metzenbauer M, Schuchter K, Philipp K: Increased nuchal translucency and congenital heart defects in a low-risk population. Prenat Diagn 2003;23:985-989.
12. Mavrides E, Cobian-Sanchez F, Tekay A, Moscoso G, Campbell S, Thilaganathan B, Carvalho JS: Limitations of using first-trimester nuchal translucency measurement in routine screening for major congenital heart defects. Ultrasound Obstet Gynecol 2001;17:106-110.
13. Orvos H, Wayda K, Kozinszky Z, Katona M, Pal A, Szabo J: Increased nuchal translucency and congenital heart defects in euploid fetuses. The Szeged experience. Eur J Obstet Gynecol Reprod Biol 2002;101:124-128.
14. Schwarzler P, Carvalho JS, Senat MV, Masroor T, Campbell S, Ville Y: Screening for fetal aneuploidies and fetal cardiac abnormalities by nuchal translucency thickness measurement at 10-14 weeks of gestation as part of routine antenatal care in an unselected population. Br J Obstet Gynaecol 1999;106:1029-1034.
15. Zosmer N, Souter VL, Chan CS, Huggon IC, Nicolaides KH: Early diagnosis of major cardiac defects in chromosomally normal fetuses with increased nuchal translucency. Br J Obstet Gynaecol 1999;106:829-833.
16. Makrydimas G, Sotiriadis A, Ioannidis JP: Screening performance of first-trimester nuchal translucency for major cardiac defects: a meta-analysis. Am J Obstet Gynecol 2003;189:1330-1335.
17. Taipale P, Ammala M, Salonen R, Hiilesmaa V: Learning curve in ultrasonographic screening for selected fetal structural anomalies in early pregnancy. Obstet Gynecol 2003;101:273-278.